Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€254.50

€254.50

0.980%
2.5
0.980%
€302.43
 
10.07.25 / Tradegate WKN: A0MQX8 / Symbol: PODD / Name: Insulet / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15
JavaScript chart by amCharts 3.21.15JS chart by amCharts
Select a timeframe to show chart data
From: to:
Zoom:
Loading data...
Your prediction

Insulet Corp. Stock

Insulet Corp. gained 0.980% compared to yesterday.
The stock is an absolute favorite of our community with 29 Buy predictions and no Sell predictions.
With a target price of 302 € there is a slightly positive potential of 18.66% for Insulet Corp. compared to the current price of 254.5 €.
So far the community has only identified positive things for Insulet Corp. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Insulet Corp. in the next few years

Pros
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Insulet Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Insulet Corp. 0.980% -0.702% -2.677% 39.376% 1.112% 9.959% 38.315%
Bio-Rad Labs Inc. A 1.370% -1.263% 4.559% -17.060% -32.824% -58.448% -49.034%
Neogen Corp. -5.750% -1.389% -13.061% -68.905% -64.500% - -
Haemonetics Corp. 3.910% -0.775% 3.226% -18.987% -15.232% -0.775% -16.340%

Comments

Insulet Corporation (NASDAQ: PODD) had its "buy" rating re-affirmed by analysts at Citigroup Inc..
Ratings data for PODD provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -4.36%
Target price 316.528
Change
Ends at 16.06.26

Insulet Co. (NASDAQ: PODD) is now covered by analysts at Truist Financial Co.. They set a "buy" rating and a $365.00 price target on the stock.
Ratings data for PODD provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -10.51%
Target price 334.552
Change
Ends at 30.05.26

Insulet Co. (NASDAQ: PODD) is now covered by analysts at The Goldman Sachs Group, Inc.. They set a "buy" rating and a $380.00 price target on the stock.
Ratings data for PODD provided by MarketBeat
Show more

News

3 Medical Technology Stocks Outperforming in 2025: https://www.marketbeat.com/logos/articles/med_20250605161905_3-medical-technology-stocks-outperforming-in-2025.png
3 Medical Technology Stocks Outperforming in 2025

As the broader market stages a sharp rebound from its April lows, several sectors, industries, and stocks have quietly emerged as leaders. Among them, the medical technology industry, known for

Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer: https://www.marketbeat.com/logos/articles/med_20250513152714_insulet-earnings-propel-stock-and-an-sp-500-leader.jpg
Insulet Surges on Q1 Beat, Emerges as a Top S&P 500 Performer
[content-module:CompanyOverview|NASDAQ:PODD]

Insulet Corporation’s (NASDAQ: PODD) recent outperformance has caught investors' attention and has earned it a designation as a top performer on the